Understanding Cannabidiol Use in Older Adults
Knowledges and Use of Cannabidiol in Older Adults Aged 65 Years and Over in France
This study is trying to find out how many older adults in France use CBD and what they know about it, to see if it's safe for them given their health conditions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 140 (estimated) |
| Ages | 65 Years to 120 Years |
| Sex | All |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT06094582 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the prevalence and knowledge of cannabidiol (CBD) use among older adults aged 65 and over in France, particularly those admitted to a frailty clinic. It will involve administering a questionnaire to gather data on their experiences and understanding of CBD, which is often marketed as having minimal adverse effects. The study seeks to identify potential risks associated with CBD use in this population, especially considering their common comorbidities and medication interactions. By enhancing knowledge about CBD, the study aims to inform better practices and safety measures for older adults using this substance.
Who should consider this trial
Good fit: Ideal candidates for this study are older adults aged 65 and over who are admitted to the frailty clinic at Toulouse University Hospital.
Not a fit: Patients with major cognitive disorders or those under legal supervision or guardianship will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights that enhance the safety and efficacy of CBD use among older adults.
How similar studies have performed: While there is limited data on CBD use specifically in older adults, similar studies on CBD's effects in various populations have shown promising results, indicating a need for further exploration in this demographic.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * admitted to the frailty clinic, in Toulouse University Hospital during the recruitment period. Exclusion Criteria: * major cognitive disorder with Mini Mental State Examination \<20 * being under legal supervision or guardianship.
Where this trial is running
Toulouse
- University Hospital Toulouse — Toulouse, France (Recruiting)
Study contacts
- Principal investigator: Sandrine SOURDET, MD — University Hospital, Toulouse
- Study coordinator: Sandrine SOURDET, MD
- Email: sourdet.s@chu-toulouse.fr
- Phone: 05 61 77 79 29
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.